Coherus Oncology, Inc.
- Last sale
- Nov 12, 2026 · -7.54%
- Market cap
- $83.36M
- 154.54M shares
- Filings
- 923
Q3 2026+59.8% FY25 yoy
Q3 2026+489.4% FY25 yoy
Q3 2026N/M FY25 yoy
FY 2023derivedN/M FY23 yoy
Q3 2026+472.0% FY25 yoy
Q3 2026−29.5% FY25 yoy
- $83.36M
- —
- 1.6×
- 3.3×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $42,172,000 | reported | |
| FY 2024 | 2024-12-31 | $26,389,000 revised | reported | |
| FY 2023 | 2023-12-31 | $257,244,000 | reported | |
| FY 2022 | 2022-12-31 | $211,042,000 | reported | |
| FY 2021 | 2021-12-31 | $326,551,000 | reported | |
| FY 2020 | 2020-12-31 | $475,824,000 | reported | |
| FY 2019 | 2019-12-31 | $356,071,000 | reported | |
| FY 2018 | 2018-12-31 | $0 | reported | |
| FY 2017 | 2017-12-31 | $1,556,000 | reported | |
| FY 2016 | 2016-12-31 | $189,476,000 revised | reported | |
| FY 2015 | 2015-12-31 | $30,041,000 | reported | |
| FY 2014 | 2014-12-31 | $31,106,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2014 | — | $2.00K | $2.00K | — | 33.32M sh | +588.8% | — |
Segments
Products
LineFY2025ShareChange
Toripalimab$40.84M97%+113.5%
Other revenue$1.34M3.2%−81.6%
CIMERLI———
UDENYCA———
YUSIMRY———
Total$42.17M
Biological products, except diagnostic substances
Coherus Oncology, Inc. is the 45th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
BSEMBioStem Technologies, Inc.$47.5M31.8%13.9%$24.7MFENCFennec Pharmaceuticals Inc.$44.6M6.1%21.8%$381.4M
CHRSCoherus Oncology, Inc. (this company)$42.2M59.8%398.4%$83.4M
EDITEditas Medicine, Inc.$40.5M25.4%395.0%$329.5MVYGRVoyager Therapeutics, Inc.$40.4M49.5%296.5%$105.8MSGMOQSangamo Therapeutics, Inc$39.6M31.6%310.8%$58.0MKYMRKymera Therapeutics, Inc.$39.2M16.7%794.0%$10.9BCCCCC4 Therapeutics, Inc.$35.9M1.0%292.1%$405.1MXFORX4 Pharmaceuticals, Inc$35.1M1,273.2%225.6%$324.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Coherus Oncology, Inc. · CIK 1512762 · Engraved from SEC EDGAR